Articles with public access mandates - GETINET M ADINEWLearn more
Not available anywhere: 1
Role of Flavonoid Activation of Nrf2 in Neurodegenerative Disease and Brain Aging
E Taka, GM Adinew, KFA Soliman
Flavonoids and Anti-Aging, 61-87, 2023
Mandates: US National Institutes of Health
Available somewhere: 14
Epigallocatechin-3-Gallate (EGCG): New therapeutic perspectives for neuroprotection, aging, and neuroinflammation for the modern age
A Payne, S Nahashon, E Taka, GM Adinew, KFA Soliman
Biomolecules 12 (3), 371, 2022
Mandates: US National Institutes of Health
The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
SSMKFAS Getinet M. Adinew , Equar Taka, Patricia Mendonca
Nutrients 13 (4), 1212, 2021
Mandates: US National Institutes of Health
Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity
E Pajarillo, J Johnson, A Rizor, I Nyarko-Danquah, G Adinew, J Bornhorst, ...
Journal of Biological Chemistry 295 (46), 15662-15676, 2020
Mandates: US National Institutes of Health
Neurotoxicity mechanisms of manganese in the central nervous system
E Pajarillo, I Nyarko-Danquah, G Adinew, A Rizor, M Aschner, E Lee
Advances in neurotoxicology 5, 215-238, 2021
Mandates: US National Institutes of Health
Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment
REKFAS Getinet M. Adinew,Equar Taka ,Bereket Mochona ,Ramesh B Badisa ...
Nutrients 14 (1), 79, 2021
Mandates: US National Institutes of Health
The prognostic and therapeutic implications of the chemoresistance gene BIRC5 in triple-negative breast cancer
GM Adinew, S Messeha, E Taka, KFA Soliman
Cancers 14 (21), 5180, 2022
Mandates: US National Institutes of Health
Anticancer effects of thymoquinone through the antioxidant activity, upregulation of Nrf2, and downregulation of PD-L1 in triple-negative breast cancer cells
GM Adinew, SS Messeha, E Taka, RB Badisa, KFA Soliman
Nutrients 14 (22), 4787, 2022
Mandates: US National Institutes of Health
Molecular mechanisms of the anti-inflammatory effects of epigallocatechin 3-gallate (EGCG) in LPS-Activated BV-2 microglia cells
A Payne, E Taka, GM Adinew, KFA Soliman
Brain Sciences 13 (4), 632, 2023
Mandates: US National Institutes of Health
Thymoquinone alterations of the apoptotic gene expressions and cell cycle arrest in genetically distinct triple-negative breast cancer cells
GM Adinew, SS Messeha, E Taka, RB Badisa, LM Antonie, KFA Soliman
Nutrients 14 (10), 2120, 2022
Mandates: US National Institutes of Health
The role of apoptotic genes and protein-protein interactions in triple-negative breast cancer
GM Adinew, S Messeha, E Taka, SA Ahmed, KFA Soliman
Cancer Genomics & Proteomics 20 (3), 247-272, 2023
Mandates: US National Institutes of Health
Comparative analysis of the effectiveness of narrow-spectrum versus broad-spectrum antibiotics for the treatment of childhood pneumonia
CA Demeke, GM Adinew, TB Abebe, AT Gelaye, SGH Gemeda, ...
SAGE open medicine 9, 20503121211044379, 2021
Mandates: US National Institutes of Health
Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells
GM Adinew, S Messeha, E Taka, B Mochona, KK Redda, KFA Soliman
International Journal of Molecular Sciences 24 (12), 9878, 2023
Mandates: US National Institutes of Health
The anticancer effects of flavonoids through miRNAs modulations in triple-negative breast cancer. Nutrients. 2021; 13: 1212
GM Adinew, E Taka, P Mendonca, SS Messeha, KFA Soliman
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
Mandates: US National Institutes of Health
The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer. Cancers 2022, 14, 5180
GM Adinew, S Messeha, E Taka, KFA Soliman
s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program